Trial · NCT03478774
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | pCO2 increase in kPa/min | 15 or 30 minutes (maximum apnea time) | pCO2 will be measured transcutaneously throughout the apnea period |
| Secondary | Lowest Saturation | During apnea period (until end-point is met or max. 15 or 30 minutes) | Lowest SpO2 in % |
| Secondary | Change in PaO2 in kPa | During apnea period (until end-point is met or max. 15 or 30 minutes) | Blood gas analyses as well as transcutaneous measurement |
| Secondary | Change in cardiac output in L/min | During apnea period (until end-point is met or max. 15 or 30 minutes) | Cardiac output will be measured using pulse pressure measurement |
| Secondary | Change in cerebral perfusion in % | During apnea period (until end-point is met or max. 15 or 30 minutes) | Near infrared spectroscopy will be measured continuously |
| Secondary | Changes in end-expiratory lung impedance | During apnoea time (until end-point is met or max. 15 or 30 minutes) | To quantify atelectasis during apnoeic oxygenation |
| Secondary | Change in invasive blood pressure | During apnoea time (until end-point is met or max. 15 or 30 minutes) | Measurement of change due to hypercarbia |
| Secondary | Standard monitoring | During apnoea time (until end-point is met or max. 15 or 30 minutes) | 3 pole ECG |
| Secondary | Depth of anaesthesia | During apnoea time (until end-point is met or max. 15 or 30 minutes) | Using Narcotrend-EEG |
| Secondary | Bilateral brain oxygenation | During apnoea time (until end-point is met or max. 15 or 30 minutes) | Using NIRS |
| Secondary | Arterial blood gas analyses | At 0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes of apnoea or 0,1,3,5,7,9,13,15,17,19,21,23,25,27,29 and 30 min of apnoea. | pH |
| Secondary | Arterial blood gas analyses | At 0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes of apnoea or 0,1,3,5,7,9,13,15,17,19,21,23,25,27,29 and 30 min of apnoea. | pCO2 in mmhg |
| Secondary | Arterial blood gas analyses | At 0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes of apnoea or 0,1,3,5,7,9,13,15,17,19,21,23,25,27,29 and 30 min of apnoea. | pO2 in mmhg |
| Secondary | Arterial blood gas analyses | At 0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes of apnoea or 0,1,3,5,7,9,13,15,17,19,21,23,25,27,29 and 30 min of apnoea. | SaO2 in % |
| Secondary | Arterial blood gas analyses | At 0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes of apnoea or 0,1,3,5,7,9,13,15,17,19,21,23,25,27,29 and 30 min of apnoea. | Potassium in mmol |
| Secondary | Arterial blood gas analyses | At 0, 1, 3, 5, 7, 9, 11, 13 and 15 minutes of apnoea or 0,1,3,5,7,9,13,15,17,19,21,23,25,27,29 and 30 min of apnoea. | Bicarbonate in mmol |
| Secondary | Postoperative questionnaire | Morning of first postoperative day | Visual analogue scale (VAS) : pain, nausea, vomiting, feeling worried or anxious, feeling sad or depressed, injuries, discomfort, any complications |
| Secondary | Standard monitoring | During apnoea time (until end-point is met or max. 15 or 30 minutes) | Pulse oximetry SpO2 in % |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03478774/registered